What is MOR's gross margin?

MorphoSys (MOR) has a gross margin of 86% and a net margin of -1144%.

What is MOR's P/E ratio?

Track MorphoSys (MOR) P/E ratio, ROE, and valuation metrics over time.

Where can I see MOR's full financials?

See MorphoSys (MOR) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

MorphoSys (MOR) Financials — Revenue, Earnings, Cash Flow

Also trades as: MOR.DE (XETRA) · $vol 5M · MPSYF (OTC) · $vol 0M · MOR.SW (SIX)

$18.96

Last traded 2024-08-09 — delisted

NASDAQ · Healthcare · Biotechnology · $2.9B mcap · 902436 float · 9.19% daily turnover

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$204M

Revenue

-31.9% YoY

$-460M

Net Income

-536.3% YoY

$-283M

Free Cash Flow

+7.9% YoY

86.0%

Gross Margin

-960.1%

Op. Margin

-1143.7%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE559.1%

ROA-22.7%

ROIC56.0%

Valuation

P/E-12.2

P/B47.1

EV/EBITDA0.0

Leverage

Debt/Equity-1.00

Current Ratio1.38

Interest Cov.-3.6x

Quality Scores

Piotroski F2/9

Altman Z—

Beneish M-6.35